Disclosure 0001214659-26-010474-1

SEC FORM 4

$11,534.50

Aquestive Therapeutics, Inc. (AQST)

Disposition (code F) of 2,714 shares at $4.25 per share.

Reporting Person Korczynski Sherry · Officer Title Chief Commercial Officer · Transaction Code F

Traded Aug 14, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0001214659-26-010474 · filed 2026-08-17 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Aquestive Therapeutics, Inc. (AQST)." Disclosed 2026-08-17. https://desqlong.com/cards/0001214659-26-010474-1 (retrieved 2026-09-26).